A clinical study to evaluate Safety, In-Use Tolerability and Efficacy of HARF-042202 in healthy adults with mild to moderate acne and acne prone skin. - NI

Himalaya Wellness Company0 个研究点目标入组 102 人开始时间: 待定最近更新: 2024年5月27日

试验速览

暂无简介。

•1)Subjects having good general health as determined by the Investigator on the basis of medical history. Subjects with acne-prone skin and with mild to moderate acne condition as per IGA scale and acne prone skin.
•2)Subjects with oily skin having Sebumeter measurement > 180 (µg/cm2).
•3)Female subjects of childbearing potential must have a negative urine pregnancy test performed on screening and enrolment visit.
•4)Subjects who are not under any dermatologic treatment for acne and scar/ prescribed medications.

•1)Subjects with drug induced acne as disclosed by subjects.
•2)Subjects undergoing treatment for skin lightening or subjects using other marketed skin lightening products during the study period or in the past 6 weeks.
•3)Subjects who are receiving topical or systemic treatments for acne or acne marks.
•4)Subjects receiving medications (e.g., steroids or anti-histamines) which would compromise the study.

发起方